Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$428,161
+$7,412 QoQ
Shares Held
854
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,831
of 2,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $1,870,524 across 10 Diagnostics & Research names. TMO ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,702 | $896,000 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
854 | $428,161 | |
| 3 | NEO |
Neogenomics Inc
|
19,500 | $284,505 | |
| 4 | WAT |
Waters Corp /De/
|
394 | $147,765 | |
| 5 | DGX |
Quest Diagnostics Inc
|
400 | $84,780 | |
| 6 | DHR |
Danaher Corp /De/
|
76 | $14,476 | |
| 7 | LH |
Labcorp Holdings Inc.
|
32 | $8,960 | |
| 8 | OPK |
Opko Health, Inc.
|
2,100 | $3,150 |
All Filings in TMO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $428,161 | 854 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $420,749 | 856 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $496,009 | 856 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $418,087 | 862 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $347,073 | 856 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $425,945 | 856 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $450,519 | 866 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $543,104 | 878 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $489,405 | 885 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $533,550 | 918 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $521,766 | 983 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $555,774 | 1,098 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $607,317 | 1,164 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $672,623 | 1,167 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $639,901 | 1,162 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $572,110 | 1,128 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $615,536 | 1,133 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $672,159 | 1,138 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $789,344 | 1,183 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $675,883 | 1,183 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $604,355 | 1,198 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $562,260 | 1,232 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $585,485 | 1,257 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $562,054 | 1,273 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $471,766 | 1,302 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $366,411 | 1,292 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||